Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
Authors: Gabriel N. Hortobagyi | Salomon M. Stemmer | Howard A. Burris | Yoon-Sim Yap | Gabe S. Sonke | Shani Paluch-Shimon | Mario Campone | Kimberly L. Blackwell | Fabrice André | Eric P. Winer | Wolfgang Janni | Sunil Verma | Pierfranco Conte | Carlos L. Arteaga | David A. Cameron | Katarina Petrakova | Lowell L. Hart | Cristian Villanueva | Arlene Chan | Erik Jakobsen | Arnd Nusch | Olga Burdaeva | Eva-Maria Grischke | Emilio Alba | Erik Wist | Norbert Marschner | Anne M. Favret | Denise Yardley | Thomas Bachelot | Ling-Ming Tseng | Sibel Blau | Fengjuan Xuan | Farida Souami | Michelle Miller | Caroline Germa | Samit Hirawat | Joyce O’Shaughnessy
|